Gene And Use Thereof
    4.
    发明申请

    公开(公告)号:US20170218461A1

    公开(公告)日:2017-08-03

    申请号:US15412746

    申请日:2017-01-23

    Abstract: The present invention relates to the field of biotechnology, in particular to genes and use thereof. The present invention employs whole genome sequencing to perform whole genome re-sequencing on a large number of individuals of the honey bee Apis mellifera sinisxinyuan, and obtains genes specific to the A. m. sinisxinyuan. The genes play important roles in the differentiation of A. m. sinisxinyuan from the honey bees in other regions and in the adaptive evolution of A. m. sinisxinyuan to the local environment. The Foxo gene or the Ebony gene provided in the present invention can be used to identify A. m. sinisxinyuan from other subspecies; can also be used for studying the genetic diversity of species resources of bees; and can further be used for studying cold resistance genes. This will fill the gap in the research field of A. m. sinisxinyuan by Chinese researchers.

    Modified apidaecin derivatives as antibiotic peptides
    6.
    发明授权
    Modified apidaecin derivatives as antibiotic peptides 有权
    改性apidaecin衍生物作为抗生素肽

    公开(公告)号:US09556228B2

    公开(公告)日:2017-01-31

    申请号:US14346624

    申请日:2012-09-21

    CPC classification number: C07K7/08 A61K38/00 A61K38/10 C07K14/43572

    Abstract: This invention relates to modified antibiotic peptides, particularly for use in medicine. The invention further relates to compositions and methods for destroying microorganisms, such as bacteria, viruses or fungi, and to methods for treating microbial infections. The object of the invention is to develop novel antibiotic peptides, particularly having enhanced antibiotic activity and an expanded spectrum of activity against other strains of bacteria, particularly gram-positive bacteria such as Staphylococcus aureus. According to the invention, the object is attained in a first aspect by a peptide according to claim 1.

    Abstract translation: 根据本发明,在第一方面的目的是通过权利要求1的肽。

    Allergens and allergoids from bee venom
    9.
    发明授权
    Allergens and allergoids from bee venom 有权
    来自蜂毒的过敏原和过敏原

    公开(公告)号:US08637037B2

    公开(公告)日:2014-01-28

    申请号:US12809503

    申请日:2008-12-16

    CPC classification number: A61K39/35 C07K14/43572 C12N9/16 C12N9/20 C12N9/2408

    Abstract: The present invention concerns the preparation of purified allergens and allergoids, both derived from whole bee venom, for the desensitization (immunotherapy) of subjects affected by a specific allergy. In particular, the present invention concerns a preparation for immunotherapy based on purified bee venom, characterized in that said bee venom is essentially mellitin-free. In addition, the preparation of a monomeric allergoid obtainable through the carbamylation or thiocarbamylation reaction of said mellitin-free bee venom, is described. Said allergoid, being characterized by reduced IgE-binding activity, may be a safer and more effective candidate for specific immunotherapy.

    Abstract translation: 本发明涉及由整个蜂毒衍生的纯化过敏原和过敏原的制备,用于受特定过敏影响的受试者的脱敏(免疫疗法)。 特别地,本发明涉及一种基于纯化的蜂毒素的免疫疗法的制备方法,其特征在于所述的蜂毒素基本上不含麦角蛋白。 此外,描述了通过所述不含蜂毒毒素的蜂毒素的氨基甲酰化或硫代氨基甲酰化反应获得的单体过敏物质的制备。 以IgE结合活性降低为特征的所述过敏性物质可能是特异性免疫治疗的更安全和更有效的候选物。

Patent Agency Ranking